XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1Close
Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 6,788 $ 7,822
Investments 1,068 925
Accounts receivable, net 25,111 17,722
Inventories 5,173 5,645
Other current assets 2,664 2,169
Assets of businesses held for sale 5,411 3,068
Total current assets 46,215 37,351
Long-term investments 15,944 17,985
Reinsurance recoverables 4,595 4,835
Property and equipment 3,551 3,695
Goodwill 44,258 44,259
Other intangible assets 30,176 30,863
Other assets 3,276 3,421
Separate account assets 7,431 7,430
Assets of businesses held for sale, non-current 0 2,922
TOTAL ASSETS 155,446 152,761 Close
Liabilities    
Current insurance and contractholder liabilities 5,616 5,514
Pharmacy and other service costs payable 27,503 19,815
Accounts payable 9,275 8,553
Accrued expenses and other liabilities 9,003 9,955
Short-term debt 1,717 2,775
Liabilities of businesses held for sale 2,259 2,104
Total current liabilities 55,373 48,716
Non-current insurance and contractholder liabilities 10,449 10,904
Deferred tax liabilities, net 6,953 7,173
Other non-current liabilities 3,538 3,441
Long-term debt 30,175 28,155
Separate account liabilities 7,431 7,430
Liabilities of businesses held for sale, non-current 0 591
TOTAL LIABILITIES 113,919 106,410 Close
Contingencies — Note 16
Redeemable noncontrolling interests 0 107
Shareholders' equity    
Common stock [1] 4 4
Additional paid-in capital 31,048 30,669
Accumulated other comprehensive loss (2,442) (1,864)
Retained earnings 42,132 41,652
Less: Treasury stock, at cost (29,410) (24,238)
TOTAL SHAREHOLDERS' EQUITY 41,332 46,223
Other noncontrolling interests 195 21
Total equity 41,527 46,244 Close
Total liabilities and equity $ 155,446 $ 152,761
[1] Par value per share, $0.01; shares issued, 402 million as of June 30, 2024 and 400 million as of December 31, 2023; authorized shares, 600 million.